Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants

被引:0
|
作者
Yan-Jun Xu
Paramjit S. Tappia
Nirankar S. Neki
Naranjan S. Dhalla
机构
[1] St. Boniface Hospital Research,Department of Physiology, Institute of Cardiovascular Sciences, Faculty of Medicine, University of Manitoba
[2] St. Boniface Hospital Research,Asper Clinical Research Institute
来源
Heart Failure Reviews | 2014年 / 19卷
关键词
Oxidative stress; Atherosclerosis; Resveratrol; Cardiovascular disease; Diabetes; Antioxidants;
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress is considered to play an important role in the pathogenesis of diabetes-induced cardiovascular disease (CVD), which is invariably associated with abnormal blood lipid profile, insulin resistance and metabolic syndrome. Stress, smoking, high saturated fat intake as well as low fruit and vegetable intakes have been shown to increase oxidative stress and hyperlipidemia, which increase the predisposition of diabetic subjects to atherosclerosis, stroke and coronary heart disease. The oxidation of low-density lipoprotein by oxidative stress is essential for the development of atherosclerosis, and the reduction in oxidative stress as well as blood glucose and cholesterol is considered critical for the prevention of diabetes-induced CVD. Although epidemiological studies have demonstrated that vitamin C and vitamin E decrease the incidence of coronary heart disease, different clinical trials have failed to support the beneficial effect of these antioxidants. Nonetheless, it has been suggested that natural forms of these vitamins may be more efficacious than synthetic vitamins, and this may explain the inconsistencies in results. Antioxidants, N-acetyl-l-cysteine and resveratrol, have also been shown to attenuate the diabetes-induced cardiovascular complications. It has been indicated that the antioxidant therapy may be effective in a prevention strategy rather than as a treatment for CVD. The evidence presented here supports the view that cardiovascular complications in diabetes may be induced by oxidative stress and appropriate antioxidant therapy may be promising for attenuating the progression of diabetes-induced CVD.
引用
收藏
页码:113 / 121
页数:8
相关论文
共 50 条
  • [21] Chelation therapy: overlooked in the treatment and prevention of diabetes complications?
    Frizzell, Norma
    Baynes, John W.
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (10) : 1075 - 1078
  • [22] The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications
    Jialal, Ishwarlal
    Kaur, Harmeet
    CURRENT DIABETES REPORTS, 2012, 12 (02) : 172 - 179
  • [23] The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
    Shraim, Bara A.
    Moursi, Moaz O.
    Benter, Ibrahim F.
    Habib, Abdella M.
    Akhtar, Saghir
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [24] Hypercoagulability Impairs Plaque Stability in Diabetes-Induced Atherosclerosis
    Ambreen, Saira
    Fatima, Sameen
    Elwakiel, Ahmed
    Rana, Rajiv
    Singh, Kunal
    Gupta, Anubhuti
    Gupta, Dheerendra
    Khawaja, Hamzah
    Manoharan, Jayakumar
    Besler, Christian
    Laufs, Ulrich
    Kohli, Shrey
    Isermann, Berend
    Shahzad, Khurrum
    NUTRIENTS, 2022, 14 (10)
  • [25] Centella asiatica ameliorates diabetes-induced stress in rat tissues via influences on antioxidants and inflammatory cytokines
    Masola, Bubuya
    Oguntibeju, Oluwafemi O.
    Oyenihi, Ayodeji B.
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 : 447 - 457
  • [26] Echinacea purpurea root extract modulates diabetes-induced renal dysfunction in rats through hypoglycemic, antioxidants, and anti-inflammatory activities
    Mohammedsaleh, Zuhair M.
    Aljadani, Haya M. A.
    MEDICAL SCIENCE, 2021, 25 (111) : 1033 - 1043
  • [27] Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications?
    Shaw, Andrew
    Doherty, Mary K.
    Mutch, Nicola J.
    MacRury, Sandra M.
    Megson, Ian L.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 928 - 933
  • [28] Cardiovascular complications in type 1 diabetes mellitus
    Brindisi, M. -C.
    Bouillet, B.
    Verges, B.
    Halimi, S.
    DIABETES & METABOLISM, 2010, 36 (05) : 341 - 344
  • [29] Pathology of Diabetes-Induced Immune Dysfunction
    Alexander, Michael
    Cho, Eric
    Gliozheni, Eiger
    Salem, Yusuf
    Cheung, Joshua
    Ichii, Hirohito
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [30] Diabetes-induced metabolic abnormalities in myocardium: Effect of antioxidant therapy
    Kowluru, RA
    Engerman, RL
    Kern, TS
    FREE RADICAL RESEARCH, 2000, 32 (01) : 67 - 74